Tscan Therapeutics
Recent Patents
Filed a patent for "lipid nanoparticles for delivery of nucleic acids and vaccine for the prevention of coronavirus infection" on Thu, December 22, 2022
New US PatentFiled a patent for "magea1 immunogenic peptides, binding proteins recognizing magea1 immunogenic peptides, and uses thereof" on Wed, October 5, 2022
New US PatentFiled a patent for "multiplexed t cell receptor compositions, combination therapies, and uses thereof" on Wed, October 5, 2022
New US PatentFiled a patent for "prame immunogenic peptides, binding proteins recognizing prame immunogenic peptides, and uses thereof" on Wed, October 5, 2022
New US PatentFiled a patent for "prame immunogenic peptides, binding proteins recognizing prame immunogenic peptides, and uses thereof" on Mon, November 7, 2022
New US PatentFiled a patent for "multiplexed t cell receptor compositions, combination therapies, and uses thereof" on Mon, November 7, 2022
New US PatentFiled a patent for "magea1 immunogenic peptides, binding proteins recognizing magea1 immunogenic peptides, and uses thereof" on Thu, August 31, 2023
New US PatentFiled a patent for "binding proteins recognizing hpv16 e7 antigen and uses thereof" on Thu, August 31, 2023
New US PatentFiled a patent for "binding proteins recognizing ha-1 antigen and uses thereof" on Thu, December 14, 2023
New US PatentFiled a patent for "magea1 immunogenic peptides, binding proteins recognizing magea1 immunogenic peptides, and uses thereof" on Thu, May 25, 2023
New US Patent